Pralatrexate

CAS 146464-95-1 3 current recordsSmall Molecule

Who holds supplier records for Pralatrexate? 3 organisations hold a current record for Pralatrexate: an active US FDA Type II Drug Master File. Recorded organisation countries for current records: India (2) and Netherlands (1).

Sources: FDA Drug Master File list, EDQM certification database, FDA Orange Book. Record updated 16 Nov 2026. How we read these records

Cite as: PharmaTek, “Pralatrexate: DMF and CEP holder records”, record as of 16 Nov 2026, pharmatek.co.uk/directory/api/pralatrexate

Reading the evidence

  • 3 current records

    Several organisations hold current DMFs or CEPs. Whether any is a usable source for your grade, scale and market still needs qualification.

  • Most recorded organisations are in India

    2 of the 3 current records with a recorded country list India. Organisation country is not necessarily the manufacturing site.

  • 2 with a company-level GMP certificate on record

    These organisations have at least one current EU or UK GMP certificate somewhere. It is not matched to the site that makes this substance; check the certificate's site and scope.

Current records (3)

Organisations holding an active US FDA Type II Drug Master File or a CEP for Pralatrexate. Country is the organisation's recorded country, not necessarily the manufacturing site.

  • GLAND PHARMA LTD
    Active DMF 42631 · latest filing Sept 2025
    India Company GMP cert on record
  • Hetero Labs Limited
    Active DMF 27232 · latest filing Jun 2013
    India Company GMP cert on record
  • TAPI NL BV
    Active DMF 27298 · latest filing Aug 2013
    Netherlands
Need Pralatrexate sourced and checked?

The Sourcing Desk contacts candidates, confirms current supply, grade and site, and screens each against its regulatory record, for a buyer-paid fixed fee and never a supplier commission.

Request sourcing help

Overview

Pralatrexate is a small molecule active pharmaceutical ingredient (ChEMBL CHEMBL1201746).

Chemical identity

IUPAC name
(2S)-2-[[4-[1-(2,4-diaminopteridin-6-yl)pent-4-yn-2-yl]benzoyl]amino]pentanedioic acid
Canonical SMILES
C#CCC(CC1=CN=C2C(=N1)C(=NC(=N2)N)N)C3=CC=C(C=C3)C(=O)N[C@@H](CCC(=O)O)C(=O)O
InChIKey
OGSBUKJUDHAQEA-WMCAAGNKSA-N
Synonyms
Folotyn, NSC-754230, PDX, Pralatrexate, Pralatrexato, 10-Propargyl-10-deazaaminopterin, HSDB 7786, pralatrexatum, CHEBI:71223, RefChem:57047, L01BA05, Pralatrexate(Folotyn)

Pharmacologic class

As the US FDA states it for this active substance on product listings.

Established pharmacologic class
Folate Analog Metabolic Inhibitor

Record history

No change to the current records between 13 Nov 2026 and 16 Nov 2026.

Get an email when these records change: at most one a week, only when something changed, and only after you confirm your address. All changes this week

What these records establish

  • An active DMF means a confidential file is held by the FDA and can be referenced; the FDA does not approve or disapprove DMFs.
  • A CEP confirms monograph suitability for the EU market; it is not a GMP certificate, and the holder may not be the manufacturer.
  • Historical records show a past filing, not current supply.
  • Company GMP certificates are matched to the organisation, not to the site making this substance.
  • A substance missing from these registers is not evidence that no supplier exists.

Frequently asked questions

Which organisations hold current supplier records for Pralatrexate?

3 organisations hold an active US FDA Type II Drug Master File or a CEP for Pralatrexate: GLAND PHARMA LTD (India), Hetero Labs Limited (India) and TAPI NL BV (Netherlands). A DMF or CEP shows a regulatory filing, not current commercial availability, and the holder is not necessarily the manufacturing site.

Which Pralatrexate Drug Master Files are active?

GLAND PHARMA LTD (DMF 42631), Hetero Labs Limited (DMF 27232) and TAPI NL BV (DMF 27298). The FDA does not approve or disapprove DMFs; an active DMF can be referenced in an application once its holder issues a letter of authorisation.

How do I qualify a Pralatrexate supplier?

Confirm the DMF or CEP is current and covers your grade, obtain the letter of authorisation, identify the actual manufacturing site and check its GMP certificate and FDA inspection history, audit the site or review a recent audit, and run comparable requests for information across more than one candidate.

For suppliers

Do you supply Pralatrexate?

Send a link to a certificate, registration or filing we have missed or got wrong. We check it against the issuing register before changing anything; information we cannot check against a register is shown as supplier-reported.

Free. Payment never buys an evidence status.